X-ZELL CEO presenting breakthrough CEC research at EMUC18

X-ZELL CEO presenting breakthrough CEC research at EMUC18 Amsterdam, November 2018 – X-ZELL CEO, Dr Sebastian Bhakdi, has used the 2018 European Multidisciplinary Congress on Urological Cancers (EMUC18) in Amsterdam as a platform to present new insights into the...

X-ZELL taking centre stage at inaugural A*CCELERATE NOW expo

X-ZELL taking centre stage at inaugural A*CCELERATE NOW expo Singapore, November 2018 – X-ZELL Inc. has been one of eight promising biotechnology start-ups selected to exhibit at the inaugural A*CCELERATE NOW exhibition in Singapore. The landmark event – held in a...

X-ZELL CEO to present at EMUC18 in Amsterdam

X-ZELL CEO to present at EMUC18 in Amsterdam Amsterdam, November 2018 – X-ZELL CEO, Dr Sebastian Bhakdi, has been invited to join the 2018 European Multidisciplinary Congress on Urological Cancers (#EMUC18) in Amsterdam next month as a plenary speaker. Dr Bhakdi’s...

X-ZELL technology suite upgrade underway

X-ZELL technology suite upgrade underway Singapore, October 2018 – Cancer detection specialist, X-ZELL Inc., has announced a new version of the company’s world-unique Cryoimmunostaining™ suite. Whilst keeping details close to his chest, X-ZELL’s Head of Engineering...

More Bangkok hospitals embrace ground-breaking new liquid biopsy

Bangkok hospitals embrace ground-breaking new liquid biopsy Bangkok, October 2018 – Prostate cancer patients in Bangkok now have more access to state-of-the-art cancer detection technology than ever before. After debuting at Bangkok’s Chularat 9 Hospital at the end of...

X-ZELL officially incorporated in Singapore

X-ZELL officially incorporated in Singapore Singapore, October 2018 – X-ZELL Inc., only recently named one of Asia’s 20 most innovative health tech start-ups, is coming to Singapore. According to X-ZELL CEO, Dr Sebastian Bhakdi, the rare cell detection specialist’s...